1. Home
  2. BAFN vs ANVS Comparison

BAFN vs ANVS Comparison

Compare BAFN & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BayFirst Financial Corp.

BAFN

BayFirst Financial Corp.

N/A

Current Price

$7.95

Market Cap

40.6M

Sector

Finance

ML Signal

N/A

Logo Annovis Bio Inc.

ANVS

Annovis Bio Inc.

HOLD

Current Price

$4.30

Market Cap

53.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BAFN
ANVS
Founded
1999
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
40.6M
53.3M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
BAFN
ANVS
Price
$7.95
$4.30
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$13.50
AVG Volume (30 Days)
5.6K
4.0M
Earning Date
10-30-2025
11-12-2025
Dividend Yield
2.00%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$58,931,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.40
$1.11
52 Week High
$19.75
$6.37

Technical Indicators

Market Signals
Indicator
BAFN
ANVS
Relative Strength Index (RSI) 36.16 64.18
Support Level $8.05 $4.01
Resistance Level $8.07 $4.82
Average True Range (ATR) 0.09 0.58
MACD 0.04 0.01
Stochastic Oscillator 11.50 54.76

Price Performance

Historical Comparison
BAFN
ANVS

About BAFN BayFirst Financial Corp.

BayFirst Financial Corp is a bank holding company, it generates its revenue from interest on loans and the gain-on-sale income derived from the sale of loans into the secondary market. The company serves a broad spectrum of individuals, families, and small businesses, supported by national business lines in residential and SBA lending and technology platforms. The primary source of funding for its loans is deposits. BayFirst measures performance through net interest income after provision for loan losses, return on average assets, and return on average common equity, while maintaining appropriate regulatory leverage and risk-based capital ratios. The company has various segment such as Real Estate(Residential, Commercial, and Construction & Land), Commercial and Industrial, Consumer.

About ANVS Annovis Bio Inc.

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.

Share on Social Networks: